Your session is about to expire
← Back to Search
EyeTurn App for Strabismus
N/A
Waitlist Available
Led By Kevin E Houston, OD
Research Sponsored by Massachusetts Eye and Ear Infirmary
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
No Placebo-Only Group
Summary
This trial is developing a smartphone app to detect eye misalignment in children. The app uses the phone's camera to take pictures and measure alignment by analyzing light reflections on the eyes. Early detection can help prevent long-term vision problems.
Eligible Conditions
- Strabismus
- Crossed Eyes
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Strabismus angle with the app compared to ground truth and gold standard tests
Secondary study objectives
Perceived Value Survey
Robustness
Test-Retest repeatability of the app
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: EyeTurn AppExperimental Treatment1 Intervention
All participants will have their eye alignment measured with both the experimental device (EyeTurn app) and the clinical gold standard tests or ground truth (simulated strabismus gaze angles).
Find a Location
Who is running the clinical trial?
Massachusetts Eye and Ear InfirmaryLead Sponsor
108 Previous Clinical Trials
12,844 Total Patients Enrolled
1 Trials studying Strabismus
22 Patients Enrolled for Strabismus
National Eye Institute (NEI)NIH
553 Previous Clinical Trials
1,407,119 Total Patients Enrolled
12 Trials studying Strabismus
23,248 Patients Enrolled for Strabismus
Kevin E Houston, ODPrincipal InvestigatorMassachusetts Eye and Ear
2 Previous Clinical Trials
51 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger